Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto D'Angelo

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical Drug Investigation|April 21, 2020
Tumor-Agnostic Treatment for Cancer: When How is Better than WhereDaniele Lavacchi, Giandomenico Roviello, Alberto D'Angelo
Journal of the Intensive Care Society|March 6, 2023
Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical careRobert Chapman, Sita Shah, Alberto D'Angelo
ERJ Open Research|December 22, 2022
Nanopore-based metagenomic sequencing: a diagnostic tool in respiratory tract infectionRobert Chapman, Alberto D'Angelo, Stefan Bagby
Cancers|February 26, 2025
Recent Anti-KRAS<sup>G12D</sup> Therapies: A "Possible Impossibility" for Pancreatic Ductal AdenocarcinomaNavid Sobhani, Matteo Pittacolo, Alberto D'Angelo, et al.
International Immunopharmacology|November 4, 2021
Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospectsRaheleh Roudi, Alberto D'Angelo, Marianna Sirico, et al.
Clinical Genitourinary Cancer|July 16, 2020
Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving IssueGiandomenico Roviello, Roberto Petrioli, Donata Villari, et al.
International Journal of Clinical Oncology|November 10, 2019
Corticosteroid switch after progression on abiraterone acetate plus prednisoneGiandomenico Roviello, Navid Sobhani, Silvia Paola Corona, et al.
Molecular and Cellular Biochemistry|February 8, 2025
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapyMana Alavi, Raheleh Roudi, Alberto D'Angelo, et al.
Journal of Oncology|July 30, 2019
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than LightsGiandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, et al.
Cancers|September 14, 2024
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert OpinionNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical Drug Investigation|April 21, 2020
Tumor-Agnostic Treatment for Cancer: When How is Better than WhereDaniele Lavacchi, Giandomenico Roviello, Alberto D'Angelo
Journal of the Intensive Care Society|March 6, 2023
Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical careRobert Chapman, Sita Shah, Alberto D'Angelo
ERJ Open Research|December 22, 2022
Nanopore-based metagenomic sequencing: a diagnostic tool in respiratory tract infectionRobert Chapman, Alberto D'Angelo, Stefan Bagby
Cancers|February 26, 2025
Recent Anti-KRAS<sup>G12D</sup> Therapies: A "Possible Impossibility" for Pancreatic Ductal AdenocarcinomaNavid Sobhani, Matteo Pittacolo, Alberto D'Angelo, et al.
International Immunopharmacology|November 4, 2021
Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospectsRaheleh Roudi, Alberto D'Angelo, Marianna Sirico, et al.
Clinical Genitourinary Cancer|July 16, 2020
Treating De Novo Metastatic Castration-Sensitive Prostate Cancer With Visceral Metastases: An Evolving IssueGiandomenico Roviello, Roberto Petrioli, Donata Villari, et al.
International Journal of Clinical Oncology|November 10, 2019
Corticosteroid switch after progression on abiraterone acetate plus prednisoneGiandomenico Roviello, Navid Sobhani, Silvia Paola Corona, et al.
Molecular and Cellular Biochemistry|February 8, 2025
Current understanding of PEAK family members in regulation of cellular signaling pathways and cancer therapyMana Alavi, Raheleh Roudi, Alberto D'Angelo, et al.
Journal of Oncology|July 30, 2019
Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than LightsGiandomenico Roviello, Alberto D'Angelo, Raheleh Roudi, et al.
Cancers|September 14, 2024
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert OpinionNavid Sobhani, Alberto D'Angelo, Matteo Pittacolo, et al.
Pageof 6